Prognostic significance of diabetes mellitus in locally advanced non-small cell lung cancer

BMC Cancer

Table 1 Patient characteristics

Characteristic		Number of patients
Diabetes Mellitus	Yes	30
	No	129
Gender	Male	126
	Female	33
Age (years), median (range)		64 (40–75)
Performance status	0	90
	1	67
	2	2
Clinical Stage	IIIA	86
	IIIB	73
Histology	Adenocarcinoma	87
	Squamous cell carcinoma	54
	Large cell carcinoma	6
	Others	12
Smoking history	Current or former	119
	Never	25
	Unknown	15
Body mass index (BMI) (kg/m²)	BMI < 18.5	15
	18.5 ≤ BMI < 25	116
	25 ≤ BMI < 30	26
	BMI ≥ 30	2
Laboratory parameters, median
	White blood cell, cells/μl	7070
	Hemoglobin, g/l	13.5
	Albumin, g/dl	4.0
	AST, U/l	20
	ALT, U/l	19
	LDH, U/l	191
	Calcium, mg/dl	9.0
	Creatinine, mg/dl	0.71
	Glucose, mg/dl	102.5
Median (range) radiation dosage (Gy)		60 (46–74)
Chemotherapy regimen	CDDP + VNR	44
	CDDP + S1	46
	CBDCA + PTX	46
	Others	23

AST Alanine aminotransferase, AST Aspartate aminotransferase, LDH Lactate dehydrogenase, CDDP Cisplatin, VNR Vinorelbine, CBDCA Carboplatin, PTX Paclitaxel

ISSN: 1471-2407